← FDA DRUG APPROVALS

FDA ANDA · ANDA210593

OMEPRAZOLE

Sponsor: SPIL

APPLICATION
ANDA210593
TYPE
ANDA
ORIGINAL APPROVAL
2018-07-20
LATEST ACTION
2018-07-20
ROUTE
ORAL
DOSAGE FORM
CAPSULE, DELAYED RELEASE
MARKETING STATUS
Discontinued

Products

OMEPRAZOLE MAGNESIUMDiscontinued
OMEPRAZOLE MAGNESIUM EQ 20MG BASE · CAPSULE, DELAYED RELEASE · ORAL

Approval history

2018-07-20UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →